MACOM CFO sells 7,196 company shares
MACOM Technology Solutions Holdings, Inc. Senior VP and CFO John Kober reported a series of open-market sales of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MACOM Technology Solutions Holdings, Inc. Senior VP and CFO John Kober reported a series of open-market sales of common stock. On February 17, 2026, he sold a total of 7,196 shares at prices generally between about $236 and $248 per share under a pre-arranged Rule 10b5-1 trading plan adopted on August 14, 2025. After these transactions, he directly held 48,508 shares of MACOM common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 200 | $236.42 | $47K |
| Sale | Common Stock | 300 | $237.68 | $71K |
| Sale | Common Stock | 500 | $238.71 | $119K |
| Sale | Common Stock | 200 | $239.83 | $48K |
| Sale | Common Stock | 2,223 | $241.09 | $536K |
| Sale | Common Stock | 133 | $243.38 | $32K |
| Sale | Common Stock | 767 | $244.73 | $188K |
| Sale | Common Stock | 1,753 | $245.55 | $430K |
| Sale | Common Stock | 600 | $246.63 | $148K |
| Sale | Common Stock | 520 | $247.70 | $129K |
Footnotes (11)
- F1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on August 14, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $236.00 to $236.84. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $237.17 to $237.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $238.65 to $238.76. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $239.75 to $240.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $241.05 to $241.54. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $243.14 to $244.13. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $244.14 to $244.99. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $245.26 to $245.98. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $246.40 to $247.24. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $247.49 to $248.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MACOM (MTSI) report for John Kober?
Were the MACOM (MTSI) CFO’s stock sales under a 10b5-1 plan?
Did the MACOM (MTSI) Form 4 mention weighted-average sale prices?
AI-generated analysis. How Rhea-AI works. Not financial advice.